4164.TW · CHC
Taiwan · RS rating 32 · As of 2026-10-08
| Price | 28.00 TWD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 79 / 48 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 15 / 45 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | +146.2% |
| Sales growth Q/Q | +1.5% |
| Distance from 52-week high | +42.3% |
| Market cap (USD) | $163.9M |